#1 Clinical Trials Search in Europe

Benztropine Mesylate

This article provides an in-depth look at clinical trials involving Benztropine Mesylate, a medication commonly used to treat Parkinson’s disease and certain side effects of antipsychotic drugs. We’ll explore its various applications, potential benefits, and side effects as investigated in several clinical studies. This overview aims to give patients and caregivers a better understanding of ongoing research into this important medication.

Table of Contents

What is Benztropine Mesylate?

Benztropine Mesylate, also known by its brand name Cogentin, is a medication used in various medical treatments[1]. It belongs to a class of drugs called anticholinergics, which work by affecting certain chemical processes in the body[2].

Uses of Benztropine Mesylate

Benztropine Mesylate is primarily used for the following purposes:

  • Treatment of Parkinson’s Disease symptoms: It helps manage some of the movement-related symptoms associated with Parkinson’s disease[2].
  • Managing side effects of antipsychotic medications: It is often prescribed to reduce or prevent certain side effects caused by antipsychotic drugs, such as involuntary movements, inner restlessness, or muscle stiffness[2].
  • As an active placebo in clinical trials: In some research studies, benztropine is used as an active placebo. This means it’s used as a comparison drug that can produce some side effects similar to the main drug being studied, but without the primary therapeutic effect[3].

How Benztropine Mesylate Works

Benztropine Mesylate works by blocking the action of a neurotransmitter (a chemical messenger in the brain) called acetylcholine. By doing this, it helps to balance out the levels of different chemicals in the brain, which can help reduce certain symptoms and side effects[2].

In the context of managing side effects from antipsychotic medications, benztropine helps to counteract the excessive blockade of dopamine (another brain chemical) caused by these drugs. This can help reduce movement-related side effects like muscle stiffness or tremors[2].

Side Effects and Precautions

Like all medications, benztropine can cause side effects. Some of the common side effects include:

  • Dry mouth
  • Blurred vision
  • Constipation
  • Cognitive impairment (especially in older adults)[2]

It’s important to note that benztropine can have more pronounced effects in older individuals due to age-related changes in how the body processes medications[2]. Your doctor will carefully consider the risks and benefits before prescribing this medication, especially if you’re an older adult.

Current Research and Clinical Trials

Benztropine Mesylate is currently being studied in various clinical trials:

  • Schizophrenia treatment: A study is investigating the effects of reducing benztropine doses in older patients with schizophrenia who are taking newer antipsychotic medications. The researchers are looking at how this affects cognitive function, movement-related side effects, and psychotic symptoms[2].
  • Cocaine addiction: Another study is examining whether benztropine could help reduce cravings in people with cocaine-related disorders[4].
  • Pain management: Benztropine is being used as an active placebo in studies comparing different treatments for chronic pain conditions, such as back pain and pain related to HIV neuropathy[3][5].
  • Agitation treatment: A study is comparing the effectiveness of different medication combinations, including one with benztropine, for treating agitation in emergency room settings[6].

These ongoing studies aim to better understand how benztropine can be used effectively and safely in various medical conditions. It’s important to remember that participation in clinical trials is voluntary and should be discussed thoroughly with your healthcare provider.

Trial Focus Benztropine Mesylate Role Key Findings/Objectives
Cocaine Craving Primary intervention Evaluating efficacy in affecting stimulated craving to cocaine cues
Schizophrenia Anticholinergic agent Assessing safety and benefits of dose reduction on cognitive function and symptoms
HIV-related Neuropathy Active placebo Comparing effectiveness with amitriptyline and mexiletine for pain management
Chronic Back Pain Control medication Evaluating against antidepressants for pain relief
Multisystem Functional Somatic Disorder Active placebo Comparing with duloxetine and patient education for symptom management
Schizophrenia Treatment Adjunct therapy Managing side effects of antipsychotic medications
Temporomandibular Joint Disorder Active placebo Comparing with nortriptyline and cognitive-behavioral therapy for pain relief
Agitation in Emergency Settings Part of combination therapy Evaluating efficacy as part of “cocktail” treatment compared to quetiapine

FAQ

  • What is Benztropine Mesylate used for in clinical trials? Benztropine Mesylate is being studied for various uses, including treating side effects of antipsychotic medications, as an active placebo in pain studies, and as part of combination therapies for conditions like schizophrenia and agitation.
  • How does Benztropine Mesylate compare to other medications in trials? In some trials, Benztropine Mesylate is used as an active placebo to mimic side effects of other drugs being studied, such as antidepressants. This helps researchers better evaluate the true effects of the experimental medications.
  • What dosages of Benztropine Mesylate are typically used in clinical trials? Dosages vary depending on the study, but common ranges include 0.5 mg to 2 mg daily. Some trials use lower doses, such as 0.125 mg to 0.5 mg daily, when used as an active placebo.
  • Are there any notable side effects of Benztropine Mesylate observed in clinical trials? While specific side effects aren't detailed in the provided trial information, Benztropine Mesylate is known to have anticholinergic effects. These can include dry mouth, blurred vision, and constipation. It's often used to counteract extrapyramidal symptoms caused by other medications.
  • How long do clinical trials involving Benztropine Mesylate typically last? The duration of trials varies widely. Some studies last for 8-12 weeks, while others may continue for several months or even up to a year, depending on the specific research objectives and the condition being studied.

Ongoing Clinical Trials on Benztropine Mesylate

  • Study on Duloxetine and Benztropine Mesylate for Patients with Severe Functional Somatic Disorder

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

Glossary

  • Benztropine Mesylate: A medication used to treat Parkinson's disease and manage side effects of antipsychotic drugs. It works by blocking the action of a neurotransmitter called acetylcholine in the brain.
  • Active Placebo: A substance used in clinical trials that has its own effects but is not expected to have the specific effect being studied. It's used to help maintain blinding in studies by mimicking side effects of the experimental drug.
  • Antipsychotic: A class of medications used to manage psychosis, including delusions, hallucinations, or disordered thought, particularly in conditions like schizophrenia.
  • Extrapyramidal Symptoms (EPS): Movement disorders that can occur as side effects of antipsychotic medications. These may include involuntary movements, muscle stiffness, or tremors.
  • Anticholinergic: A type of drug that blocks the action of acetylcholine, a neurotransmitter in the brain. This can help reduce certain symptoms but may also cause side effects like dry mouth or blurred vision.
  • Randomized Controlled Trial: A type of scientific experiment where participants are randomly assigned to different treatment groups. This helps reduce bias and allows researchers to compare the effects of different interventions.
  • Cognitive-Behavioral Therapy (CBT): A type of psychotherapy that helps patients identify and change negative thought patterns and behaviors. It's often used in combination with medications in mental health treatment.
  • Temporomandibular Joint Disorder (TMD): A condition affecting the jaw joint and surrounding muscles, often causing pain and difficulty in jaw movement.
  • Functional Somatic Disorder (FSD): A group of conditions characterized by physical symptoms that cannot be fully explained by any known medical condition. These disorders can significantly impact a person's quality of life.

References

  1. https://clinicaltrials.gov/study/NCT00018200
  2. https://clinicaltrials.gov/study/NCT00715377
  3. https://clinicaltrials.gov/study/NCT00066937
  4. https://clinicaltrials.gov/study/NCT00000333
  5. https://clinicaltrials.gov/study/NCT00000793
  6. https://clinicaltrials.gov/study/NCT00457366